Conditions such as hidradenitis suppurativa (HS), vitiligo, prurigo nodularis (PN) and atopic dermatitis (AD) remain some of the most difficult skin diseases to treat. Although there have been advances in dermatology, patients living with these chronic immune disorders tend to face limited treatment options, unpredictable outcomes and lasting effects on quality of life.

At the upcoming European Academy of Dermatology and Venereology (EADV) 2025 Congress in Paris, researchers will present new data that could open up new therapeutic approaches, including late-stage trial results for oral and topical JAK inhibitors.

Unmet Needs in Dermatology

HS is a severe condition that can cause much burden to those affected by it. It causes painful nodules and abscesses, often leading to scarring and

See Full Page